You are here

Article info

Article menu

Download PDFPDF

Case Report
Ipilimumab in patients with melanoma and autoimmune disease
Free

Authors

  • Chrisann Kyi New York-Presbyterian Hospital - Weill Cornell Medical College 525 E 68th Street 10065 New York NY USA PubMed articlesGoogle scholar articles
  • Richard D Carvajal Melanoma and Immunotherapeutics Oncology ServiceMemorial Sloan Kettering Cancer Center 300 East 66th Street 10065 New York NY USA Weill Cornell Medical College 525 E 68th Street 10065 New York NY USA PubMed articlesGoogle scholar articles
  • Jedd D Wolchok Melanoma and Immunotherapeutics Oncology ServiceMemorial Sloan Kettering Cancer Center 300 East 66th Street 10065 New York NY USA Weill Cornell Medical College 525 E 68th Street 10065 New York NY USA PubMed articlesGoogle scholar articles
  • Michael A Postow Melanoma and Immunotherapeutics Oncology ServiceMemorial Sloan Kettering Cancer Center 300 East 66th Street 10065 New York NY USA Weill Cornell Medical College 525 E 68th Street 10065 New York NY USA PubMed articlesGoogle scholar articles
  1. ↵a chrisann.kyi{at}gmail.com
  2. ↵b carvajar{at}mskcc.org
  3. ↵c wolchokj{at}mskcc.org
  4. ↵d postowm{at}mskcc.org
View Full Text

Citation

Kyi C, Carvajal RD, Wolchok JD, et al
Ipilimumab in patients with melanoma and autoimmune disease
Journal for ImmunoTherapy of Cancer 2014;2:35. doi: 10.1186/s40425-014-0035-z

Publication history

  • Received July 8, 2014
  • Accepted September 3, 2014
  • First published October 14, 2014.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2014